Key result
Scoring and sirolimus-eluting balloons yield minimal lumen loss and ~5% TVR in diffuse small vessel CAD.
Why the study?
The treatment of diffuse, small vessel coronary artery disease remains challenging, with high rates of repeat revascularization and no satisfactory treatment options.
Does a combination of scoring-balloon angioplasty and sirolimus-eluting balloon angioplasty provide safe and feasible outcomes in patients with diffuse, small vessel coronary artery disease?
Does a combination of scoring-balloon angioplasty and sirolimus-eluting balloon angioplasty provide safe and feasible outcomes in patients with diffuse, small vessel coronary artery disease?
A strategy combining scoring-balloon angioplasty with sirolimus-eluting balloon angioplasty for diffuse, small vessel coronary disease demonstrated favorable angiographic results and low rates of target vessel revascularization and MACE.
Answers are grounded in this paper and cite their sources.
Supports combined scoring and sirolimus-eluting balloon strategy in diffuse small vessel CAD; leaves open confirmation in randomized trials.
Background The treatment of diffuse, small vessel coronary artery disease is challenging, with high rates of repeat revascularizations, without satisfactory treatment. We designed a prospective, single-center, single-arm study to evaluate the feasibility and safety of a new strategy for the treatment of diffuse, small vessel coronary artery disease using a systematic combination of Scoring-balloon Angioplasty and Sirolimus-eluting balloon Angioplasty (the SCA-DEB study). Methods We included patients with diffuse (lesion length ≥20 mm), small vessel (diameter 1.5–2.75 mm) coronary disease. Patients with STEMI, left-main stenosis, and a life expectancy of less than 12 months were excluded. The procedure strategy was scoring-balloon angioplasty (SBA) – WedgeNC, Brosmed, China, 1:1 diameter ratio with distal reference plus sirolimus-eluting balloon angioplasty (SEB) using Mozec balloon. If scoring balloon did not pass predilatation with 1.5 mm balloon and/or rotablation was allowed. Results From December 2022 until June 2024, 146 patients with 161 vessels were included. The mean age was 67 ± 9 years, 73% males, 97% with dyslipidemia, 56% smokers, 45% diabetics, 40% with previous myocardial infarction, 86% with previous PCI, 10% previous CABG, 10% with peripheral artery disease, 18% with previous stroke or transient ischemic attack, 10% with COPD, 33% with eGFR<60 ml/kg/min, with mean left ventricular ejection fraction 52 ± 8%. The left anterior descending artery was the most frequently treated – 45%, followed by the circumflex artery – 32%. Rotablation was necessary in 3 cases. The mean reference vessel diameter was 2.1±.74 mm, MLD 0.71±0.31 mm, %DS 67±14%. The mean lesion length was 35±15 mm treated with scoring balloon with diameters and lengths – 2.21±.22 mm and 24±5 mm; and Mozec balloons (length 33 ± 11, diameter of 2.3±.0.24 mm). Additional stent was implanted in 48 patients (33%). At 3 moths angiographic follow up for the first 91 patients demonstrated the late lumen loss of 0.01 ± 0.20 mm and net lumen gain 0.93 ± .45 mm. The final %DS was 35±12% and at follow-up 33±12%, p=.19. For a median clinical follow up of 13 [8-19] months, 4.8% (7/146) had TVR. The overall rate of MACE was 7.5% (n=11/146). Conclusions A new strategy using combination of scoring balloon angioplasty followed by sirolimus-eluting Mozec balloon inflation for the treatment of diffuse coronary artery disease gives promising angiographic and clinical outcomes results.
No takes yet. Share an insight, caveat, or question.
Vassilev et al. (2025) studied diffuse, small vessel coronary artery disease (n=146). Scoring-balloon angioplasty and sirolimus-eluting balloon angioplasty was evaluated on MACE. In patients with diffuse, small vessel coronary disease, a strategy of scoring-balloon followed by sirolimus-eluting balloon angioplasty yielded a 4.8% TVR rate and 7.5% major cardiovascular events rate at 13 months.
Synapse has enriched 10 related papers. Consider them for comparative context: